Analysts say US prescriptions for both Novo's and Lilly's oral weight loss pills fell during the holiday-shortened week, suggesting a calendar effect rather than a demand drop.
Recap by typeshit. Post by Investseekers on X.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.
He calls GLP-1 drugs useful before surgery or after regain, but says surgery stays the main option for people who need large, lasting weight loss.
An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
Only 493 people across eight small trials. The two with the most weight loss, on semaglutide and high-dose liraglutide, both reported lower spine and hip bone density.
Loading…